Physician profile
John Nicholson
NPI 1699872101
$10,894.29
in general payments reported to CMS, 2019-2025
19 companies · $231 in 2025
The $231 reported for 2025 was less than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,576 · 2020: $55.38 · 2021: $195 · 2022: $322 · 2023: $93.95 · 2024: $420 · 2025: $231.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $745.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $745.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $9,504.06 | 2019 | |
| Tela Bio, INC. | $412.02 | 2022-2024 | Ovitex 2s |
| Ferring Pharmaceuticals INC. | $179.08 | 2020-2025 | Rebyota, Clenpiq |
| Braintree Laboratories, INC. | $108.16 | 2019-2024 | Sutab, Suflave |
| Vertex Pharmaceuticals Incorporated | $107.74 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $98.31 | 2019-2022 | |
| Dexcom, INC. | $93.36 | 2022-2024 | Dexcom G6 Transmitter |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $87.00 | 2020-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $55.41 | 2024-2025 | Gattex |
| Ethicon US, LLC | $39.53 | 2025 | Evarrest |
| Acera Surgical, INC. | $34.84 | 2025 | Restrata Wound Matrix |
| Axonics, INC. | $34.06 | 2023-2024 | Axonics, Bulkamid |
| Biom'Up France Sas | $29.62 | 2021 | |
| Davol INC. | $23.16 | 2024 | Phasix Mesh |
| Medtronic, INC. | $20.20 | 2025 | Interstim |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fujifilm Healthcare Americas Corporation | $19.69 | 2023 | Fujifilm |
| Smith+Nephew, INC. | $18.08 | 2021 | |
| Acelrx Pharmaceuticals, INC. | $17.50 | 2021 | |
| Abbvie INC. | $12.47 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Nicholson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.